Clinical Use and Safety of the Xtreme Touch (Magic Touch PTA)- Neo Sirolimus Coated PTA Balloon Catheter in the Treatment of Infrainguinal Peripheral Arterial Disease

Inclusion Criteria: * Age ≥ 21 years or minimum age * Subject must be willing to sign a Patient Data Release Form or Patient Informed Consent where applicable * Lesion(s) in the infrainguinal arteries between 3 to 6mm which are suitable for endovascular treatment treated with the Xtreme Touch - Neo sirolimus PTA balloon catheter. For below the knee (BTK) arteries, lesions located in the proximal 200mm of the artery. Exclusion Criteria: * Life expectancy ≤ 1 year * Subject is currently participating in another investigational drug or device study that has not reached ist primary endpoint yet * Subject is pregnant or planning to become pregnant during the course of the study * Failure to achieve less than 30% residual stenosis in pre-existing lesion after plain balloon angioplasty * Failure to successfully cross the target lesion with a guide wire (successful crossing means tip of the guide wire distal to the target lesion in the absence of flow limiting dissections or perforations